MedPath

Multicentric study on outcome of treatment of osteosarcoma in India, conducted by Indian Musculo Skeletal Oncology Society

Not Applicable
Conditions
Health Condition 1: C40-C41- Malignant neoplasms of bone and articular cartilage
Registration Number
CTRI/2023/05/053100
Lead Sponsor
Indian Musculo Skeletal Oncology Society (IMSOS)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients with proven tissue diagnosis of osteosarcoma diagnosed on January 2001 or later, and treated in India for the same

Exclusion Criteria

Patients without histopathologically confirmed diagnosis of osteosarcoma

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall and event free survival will be assessed as primary outcome over the time period of five years.Timepoint: Five years
Secondary Outcome Measures
NameTimeMethod
Relationship of prognostic variables with overall and event free survival will be assessed as secondary outcome over the period of five years.Timepoint: Five years
© Copyright 2025. All Rights Reserved by MedPath